Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
Giornale Italiano Di Cardiologia (2006)|October 5, 2018
[Edoxaban in patients with atrial fibrillation and cancer]Nicola Maurea, Letizia RivaPharmaceuticals (Basel, Switzerland)|June 26, 2026
Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical EvidenceAmro Abu Suleiman, Vincenzo Quagliariello, Luigi Spadafora, et al.Journal of Clinical Medicine Research|January 17, 2017
The Impact Exerted on Clinical Outcomes of Patients With Chronic Heart Failure by Aldosterone Receptor Antagonists: A Meta-Analysis of Randomized Controlled TrialsRenato De Vecchis, Claudio Cantatrione, Damiana Mazzei, et al.Cancer Treatment Reviews|January 6, 2018
Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugsCarmela Coppola, Anna Rienzo, Giovanna Piscopo, et al.Frontiers in Immunology|October 29, 2020
Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From CancerAntonio Barbieri, Nirmal Robinson, Giuseppe Palma, et al.Cancer Immunology, Immunotherapy : CII|April 20, 2021
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reportsAlessandro Inno, Nicola Maurea, Giulio Metro, et al.Journal of Clinical Medicine|September 13, 2025
Factor XI and Cancer: Physiopathological Linkage and Clinical PerspectivesAlfredo Mauriello, Anna Chiara Maratea, Celeste Fonderico, et al.The Oncologist|March 16, 2016
WITHDRAWN:A Practical Approach for Management of QT Prolongation Induced by Anticancer DrugsNicola Maurea, Carmela Coppola, Giovanna Piscopo, et al.Expert Opinion on Therapeutic Targets|March 31, 2010
Circadian rhythms, adrenergic hormones and trafficking of hematopoietic stem cellsAldo Giudice, Michele Caraglia, Monica Marra, et al.Oncotargets and Therapy|May 3, 2018
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazineClaudia De Lorenzo, Rolando Paciello, Gennaro Riccio, et al.Pageof 12